- Home
- CLPS vs KZR Comparison
CLPS vs KZR Comparison
Compare CLPS & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- KZR
- Stock Information
- Founded
- CLPS 2005
- KZR 2015
- Country
- CLPS Hong Kong
- KZR United States
- Employees
- CLPS N/A
- KZR N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- KZR Health Care
- Exchange
- CLPS Nasdaq
- KZR Nasdaq
- Market Cap
- CLPS 29.7M
- KZR 29.7M
- IPO Year
- CLPS 2018
- KZR 2018
- Fundamental
- Price
- CLPS $1.23
- KZR $6.36
- Analyst Decision
- CLPS
- KZR Hold
- Analyst Count
- CLPS 0
- KZR 4
- Target Price
- CLPS N/A
- KZR $6.00
- AVG Volume (30 Days)
- CLPS 89.0K
- KZR 422.8K
- Earning Date
- CLPS 10-17-2025
- KZR 11-11-2025
- Dividend Yield
- CLPS 10.66%
- KZR N/A
- EPS Growth
- CLPS N/A
- KZR N/A
- EPS
- CLPS N/A
- KZR N/A
- Revenue
- CLPS $153,816,045.00
- KZR N/A
- Revenue This Year
- CLPS N/A
- KZR N/A
- Revenue Next Year
- CLPS N/A
- KZR N/A
- P/E Ratio
- CLPS N/A
- KZR N/A
- Revenue Growth
- CLPS 5.81
- KZR N/A
- 52 Week Low
- CLPS $0.80
- KZR $3.53
- 52 Week High
- CLPS $1.88
- KZR $8.60
- Technical
- Relative Strength Index (RSI)
- CLPS 56.36
- KZR 84.60
- Support Level
- CLPS $0.98
- KZR $4.10
- Resistance Level
- CLPS $1.88
- KZR $4.45
- Average True Range (ATR)
- CLPS 0.11
- KZR 0.32
- MACD
- CLPS 0.04
- KZR 0.17
- Stochastic Oscillator
- CLPS 29.19
- KZR 98.72
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.